对单剂量甲基化物挑战的临床反应表明,在ADHD的成年人中,在两个月后的治疗反应
Valeria Parlatini1,2,3,4,5,6, Joaquim Radua7, Hannah Thomas8
1School of Psychology, University of Southampton, Southampton, UK. valeria.parlatini@kcl.ac.uk.
Translational psychiatry
|October 6, 2025
概括
一次剂量甲基 (MPH) 可以预测长期的注意力缺陷/多动症 (ADHD) 治疗反应. 经过急性MPH使用后的临床神经心理测量,结合基线数据,可以指导个性化ADHD治疗.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 通常用甲基化 (MPH) 等兴奋剂治疗.
- 个人对MPH的反应各不相同,需要个性化治疗策略.
- 以前的研究表明,急性刺激作用可以预测长期的临床结果.
研究的目的:
- 调查单次MPH剂量后的临床和神经心理测量是否预测ADHD成人的长期治疗反应.
- 探索用于预测MPH治疗疗效的常用临床措施的实用性.
主要方法:
- 60名患有多动症的成年人接受了单剂20毫克的MPH或安慰剂.
- 进行了临床神经心理评估,包括巴克利成人多动症评分尺度-IV (BAARS-IV) 和定量行为 (Qb) 测试.
- 在MPH治疗两个月后重复测量以评估反应;使用单变量和多变量回归分析.
主要成果:
- 在BAARS过度活跃/冲动性和大多数Qb分数中,单剂量和两个月的改善之间发现了显著的关联.
- 结合急性反应和基线数据的多变量模型显示,大多数措施的预测结果与实际结果之间存在显著的相关性.
- 这些相关性的效果大小通常很大 (高达r=0.69).
结论:
- 单次MPH剂量后的急性临床神经心理变化可能表明长期的ADHD治疗反应.
- 将急性反应与基线人口统计数据相结合,可以提高预测的准确性.
- 这些发现可以在进一步验证后支持更个性化的ADHD治疗方法.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.3K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10.2K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
758
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
758
01:22Dose-Response Relationship: Potency and Efficacy
6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K
01:28Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K
01:03Dose-Response Relationship: Overview
4.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.9K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
01:29Stimulants
831
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
831